Navigation Links
Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
Date:9/30/2011

MELBOURNE, Australia, Sept. 30, 2011 /PRNewswire/ -- Circadian Technologies Limited (ASX: CIR, OTCQX:CKDXY) is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate clinical studies of VGX-100. The first trial (Phase I) will involve the treatment of a variety of different cancer types in patients with late stage cancer.  

VGX-100 is a human antibody that acts against the human VEGF-C protein.  Treatment for cancers, particularly glioblastoma and metastatic colorectal cancers, are the first target indications for VGX-100.  Additionally, Circadian is developing VGX-100 for a number of other cancer indications, as well as an agent to treat front-of the-eye diseases.

Preclinical animal model studies across a wide range of tumour types have shown that when combined with Avastin® and chemotherapy,  VGX-100 can significantly reduce tumour growth and tumour spread as well as significantly improve tumour inhibition, over and above that of Avastin® and/or chemotherapy alone. Recent studies have also implicated VEGF-C as a key mediator of disease progression during Avastin® treatment, implying that combination therapy with VGX-100 and Avastin® could significantly improve treatment outcomes in cancer patients.

"VGX-100 has the potential to significantly improve the treatment of patients suffering from cancer. The IND filing is an important milestone for us, as it completes our pre-clinical phase of development and transitions Circadian into a clinical development company. We expect to commence our first in man Phase I studies as soon as possible after FDA review. We also expect to see results from the study in the second half of 2012," stated Robert Klupacs, CEO of Circadian Technologies Limited.

Circadian's wholly owned subsidiary, Vegenics Pty Ltd, owns worldwide ri
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
2. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
3. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
4. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
5. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
6. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
7. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
8. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
9. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
10. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
11. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 InformEx, North America,s leading ... will hold the 30 th edition of its annual ... Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... fine chemical and specialty chemical companies will take part in ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ...
(Date:1/14/2014)... January 14, 2014 Equashield ( ... hazardous drugs, today announced that it has achieved ... year.   Equashield,s closed systems reduce ... nurses and other medical professionals who prepare and ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
(Date:4/23/2014)... could help doctors predict which patients might suffer potentially ... The program, which assesses brain scans using pattern recognition ... passport control, has been developed by researchers at Imperial ... the Wellcome Trust, which used the software are published ... Stroke affects over 15 million people each year worldwide. ...
(Date:4/23/2014)... 2014) The American Gastroenterological Association (AGA) Research ... Research Scholars. The AGA Research Scholar Awards program, ... independent and productive research careers in digestive diseases. ... an additional year allowing for three consecutive years ... junior faculty who are paving the way for ...
(Date:4/23/2014)... vegetables are often displayed in the popular Swedish ... plenty of high-sugar foods. A new study from ... portrayed in children,s TV programmes as well as ... habits and weight status. , Steingerdur Olafsdottir,s doctoral ... the popular Swedish children,s TV show Bolibompa. Healthy ...
(Date:4/23/2014)... Five for-profit and non-profit organizations in Washington ... Proof of Concept grants to accelerate maturation of ... the Life Sciences Discovery Fund (LSDF) announced today. ... grant to the Washington Biotechnology & Biomedical Association ... train the next generation of entrepreneurs and help ...
(Date:4/23/2014)... physicians concerned about an increase in adolescents, marijuana use ... sigh of relief. According to a new study at ... data from states with and without medical marijuana laws, ... among adolescents. The study is published online in advance ... . , "Any time a state considers legalizing ...
Breaking Medicine News(10 mins):Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2
... , , , MORRISTOWN, ... WPI ), a leader in generic and specialty branded ... Company as Executive Vice President, Global Brands. In this ... aspects of the Company,s global brand pharmaceutical business, including brand ...
... BALTIMORE, Sept. 21 A new survey from ... is contributing to acute, or short-term, physical pain for Americans. ... Month, 68 percent of people who experienced acute back pain ... year said that the recession caused, increased or affected their ...
... , , BIRMINGHAM, Ala., Sept. 21 ... that it has received a request for proposal (RFP) from the ... of intravenous (i.v) peramivir for the treatment of critically ill influenza ... The RFP indicates that the minimum and maximum order ...
... , , INDIANAPOLIS, Sept. 21 ... nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received ... as compared to placebo plus best supportive care. , ... studies looking at the use of histology to tailor treatment with ...
... DETROIT, Sept. 21 Webahn, Inc. announces the launch of ... Electronic Medical Records service Capzule.com and Accent, a voice recording ... , Capzule enables physicians to access patient information ... capability to send messages, add notes, prescribe medications and write ...
... is a serious condition that involves the formation of a ... legs. A patient with DVT is typically treated with anticoagulants ... procedures may play a more central role in the long-term ... October issue of the American Journal of Roentgenology ...
Cached Medicine News:Health News:Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands 2Health News:Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands 3Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 2Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 3Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 4Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 2Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 3Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 4Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 2Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 3Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 4Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 5Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 6Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 7Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 8Health News:Voice, Medical Records iPhone Apps Launched for Physicians 2Health News:Image-guided treatment for deep venous thrombosis could improve patients' long-term outcomes 2
... Available in small and large sizes, ... popular, easy-to-place, silver/silver chloride disposable tabs. For ... 17). Dimensions (contact surface): large tabs-2.2 x ... tabs-1.5 cm (0.5 in) square. Each 100-count ...
... Symphony orchestrates images and patient information ... information sources in one central system. ... and improves cost-effectiveness so that healthcare ... do best, helping people., ,Many Sources, ...
... Maxenon Xi300 is so bright many surgeons turn ... gears to shift into when the going gets ... as a true Hot Start and the technologically ... system that prevent failed start ups and overheating. ...
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
Medicine Products: